Time trade-off utility analysis for surgical intervention in comitant strabismus, glaucoma, and cataract

Acta Medica Okayama

Volumn 66, Issue 3, 2012, Pages 191-201

  Kishimoto, Fumiko ^a,b   Naito, Tomoko ^a   Hasebe, Satoshi ^a   Ohtsuki, Hiroshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Ibara Municipal Hospital   (Japan)

Author keywords

Quality adjusted life years; Surgical intervention; Time trade off; Utility analysis; VF 14

Indexed keywords

ADULT; AGED; ARTICLE; CATARACT EXTRACTION; FEMALE; GLAUCOMA; HUMAN; MALE; MIDDLE AGED; QUALITY ADJUSTED LIFE YEAR; STRABISMUS; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; CATARACT EXTRACTION; FEMALE; GLAUCOMA; HUMANS; MALE; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; STRABISMUS; VISUAL ACUITY;

EID: 84864755212     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Redelmeier DA and Detsky AS: A clinicians guide to utility mea surement. Prim Care (1995) 22: 271-280.
2. Brown GC, Sharma S, Brown MM and Garretts S: Evidence-based medicine and cost-effectiveness. J Health Care Finance (1999) 26: 14-23.
3. Brown GC: Vision and quality-of-life. Trans Am Ophthalmol Soc (1999)97: 473-511.
4. Brown GC, Brown MM, Sharma S, Brown H and Tasman W: Incremental cost effectiveness of laser photocoagulation for subfo- veal choroidal neovascularization. Ophthalmology (2000) 107: 1374-1380.
5. Brown GC, Brown MM and Sharma S: Cost-utility analysis. Ann Intern Med (2001) 134: 625-626.
6. Hirneiss C, Neubauer AS, Tribus C and Kampik A: "Value-based medicine" in der Augenheilkunde. Der Ophthalmologe (2006) 103: 493-500 (in German).
7. Hollands H, Lam M, Peter J, Albiani D, Brown GC, Brown M, Cruess AF and Sharma S: Reliability of the time-trade-off tech nique of utility assessment in patients with retinal disease. Can J Ophthalmol (2001) 36: 202-209.
8. Brown GC, Brown MM, Sharma S, Bauchamp G and Hollands H: The reproducibility of ophthalmic utility values. Trans Am Ophthalmol Soc (2001) 99: 199-204.
9. Brown GC and Brown MM: Comparative effectiveness. Curr Opin Ophthalmol (2009) 20: 147-150.
10. Sabri K, Knapp CM, Thompson JR and Gottlob I: The VF-14 and psychological impact of amblyopia and strabismus. Invest Ophthalmol Vis Sci (2006) 47: 4386-4392.
11. Sharma S, Brown GC, Brown MM, Hollands H, Robin SS and Shah GK: Validity of the time trade-off and standard gamble meth ods of utility assessment in retinal patients. Br J Ophthalmol (2002) 86: 493-496.
12. Weinstein MC and Stason WB: Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med (1977) 296: 716-721.
13. Brown GC, Brown MM, Sharma S, Brown H, Smithen L, Leeser D and Beauchamp G: Value-based medicine and ophthalmology: an appraisal of cost-utility analysis. Trans Am Ophthalmol Soc (2004) 102: 177-188.
14. Steinberg EP, Tielsch JM, Schein OD, Javitt JC, Sharkey P, Cassard SD, Legro MW, Diener-West M, Bass EB, Damiano AM, Steinwachs DM and Sommer A: The VF-14. An index of func tional impairment in patients with cataract. Arch Ophthalmol (1994) 112: 630-638.
15. Massof RW and Rubin GS: Visual function assessment question naires. Surv Ophthalmol (2001) 45: 531-548.
16. Brown MM, Brown GC, Sharma S and Landy J: Health care eco nomic analyses and value-based medicine. Surv Ophthalmol (2003) 48: 204-223.
17. Edelman D, Williams GR, Rothman M and Samsa GP: A compari son of three health status measures in primary care outpatients. J Gen Intern Med (1999) 14: 759-762.
18. Ware JE Jr and Sherbourne CD: The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care (1992) 30: 473-483.
19. Ellwein LB, Fletcher A, Negrel AD and Thulasiraj RD: Quality of life assessment in blindness prevention interventions. Int Ophthalmol (1995) 18: 263-268.
20. Mangione CM, Lee PP, Pitts J, Gutierrez P, Berrys S and Hays RD: Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol (1998) 116: 1496-1504.
21. Schulze-Bonsel K, Feltgen N, Burau H, Hansen L and Bach M: Visual acuities "hand motion" and "counting fingers" can be quanti fied with the Freiburg visual acuity test. Invest Ophthalmol Vis Sci (2006)47: 1236-1240.
22. Anderson DR and Patella VM: Automated static perimetry, 2nd ED, Mosby, St Louis (1999) pp 121-190.
23. Fujita A, Hieda O, Nakajima N and Kinoshita S: The VF-14 index of functional visual impairment in patients with corneal disease treated by phototherapeutic keratectomy. Nihon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc) (2005) 109: 736-740 (in Japanese).
24. Siegel JE, Weinstein MC, Russell LB and Gold MR: for the panel on cost-effectiveness in health and medicine. Recommendations for reporting cost-effectiveness analyses. JAMA (1996) 276: 1339-1341.
25. Bauchamp GR, Felius J, Stager DR and Baucchamp CL: The util ity of strabismus in adults. Trans Am Ophthalmol Soc (2005) 103: 164-172.
26. Schiffman RM, Walt JG, Jacobsen G, Doyle JJ, Lebovics G and Sumner W: Utility assessment among patients with dry eye dis ease. Ophthalmology (2003) 110: 1412-1419.
27. Brown MM, Brown GC, Sharma S, Busbee B and Brown H: Quality of life associated with unilateral and bilateral good vision. Ophthalmology (2001) 108: 643-647.
28. Senba S: Cost-utility analysis of cataract surgery: measuring of the value of preference using time trade-off method. Tokyo University, Doctorate Thesis (Medicine) 1121220, 2009.
29. Lansingh VC and Carter MJ: Use of global visual acuity data in a time trade-off approach to calculate the cost utility of cataract sur gery. Arch Ophthalmol (2009) 127: 1183-1193.
30. Busbee BG, Brown MM, Brown GC and Sharma S: Incremental cost-effectiveness of initial cataract surgery. Ophthalmology (2002) 109: 606-613.
31. Busbee BG, Brown MM, Brown GC and Sharma S: Cost-utility analysis of cataract surgery in the second eye. Ophthalmology (2003) 110: 2310-2317.
32. Beauchamp CL, Beauchamp GR, Stager DR, Brown MM, Brown GC and Felius J: The cost utility of strabismus surgery in adults. J AAPOS (2006) 10: 394-399.
33. Fujiike K, Mizuno Y, Hiratsuka Y and Yamada M: The Strabismus Surgery Study Group. Quality of life and cost-utility assessment after strabismus surgery in adults. Jpn J Ophthalomol (2011) 55: 268-276.
34. Gupta V, Srinivasan G, Mei SS, Gazzard G, Sihota R and Kapoor KS: Utility values among glaucoma patients: an impact on the quality of life. Br J Ophthalmol (2005) 89: 1241-1244.
35. Sun X, Zhang S, Wang N, Liang Y, Wang L, Fan S and Sun L: Utility assessment among patients of primary angle closure/glau coma in China: a preliminary study. Br J Ophthalmol (2009) 93: 871-874.
36. Hirneiss C, Kampik A and Neubauer AS: "Value-based medicine" bei Glaukom. Der Ophtalmologe (2010) 107: 223-227 (in German).
37. Real FJ, Brown GC, Brown HC and Brown MH: The effect of comorbidities upon patient health-related quality of life. Br J Ophthalmol (2008) 92: 770-774.
38. Umazume F, Ohtsuki H and Hasebe S: Preoperative factors influ encing effectiveness of surgery in adult strabismus. Jpn J Ophthalmol (1997)41: 89-97.
39. Umazume F, Ohtsuki H and Hasebe S: Predictors of postopera tive binocularity in adult strabismus. Jpn J Ophthalmol (1997) 41: 414-421.